ERENUMAB COMPOSITIONS AND USES THEREOF

The present invention relates to compositions comprising erenumab and one or more erenumab variants, including isomerization variants, deamidation variants, acidic variants, and HMW species. Pharmaceutical formulations comprising the erenumab compositions and methods of using and characterizing the...

Full description

Saved in:
Bibliographic Details
Main Authors LAWSON, Kenneth, RAMIREZ, Jose Gregorio, RIEDER, Noel, HAPUARACHCHI, Suminda
Format Patent
LanguageEnglish
Published 29.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compositions comprising erenumab and one or more erenumab variants, including isomerization variants, deamidation variants, acidic variants, and HMW species. Pharmaceutical formulations comprising the erenumab compositions and methods of using and characterizing the compositions are also described.
Bibliography:Application Number: SG20201109629Y